Eiman Elmileik, MD
Hematology & Oncology Physician · Providence, RI
Eiman Elmileik, MD is a hematology & oncology physician with a practice address in Providence, Rhode Island, and NPI 1588314637, issued on Mar 23, 2022. Check the license (Rhode Island LP06490, as entered in NPPES) on the Rhode Island Board of Medical Licensure and Discipline; the Medicare figures below come from public CMS files.
- Name
- Eiman Elmileik
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- LP06490 RI
125080358 IL
Self-reported in NPPES; status is on the state search - Practice location
- 593 Eddy St, Providence, RI 02903
- Phone
- (401) 444-9375
- Enumerated
- Mar 23, 2022
- Record last updated
- Jun 10, 2025
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 88 in Rhode Island → Look up another NPI →
Also registered at 593 Eddy St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Farah AbazaStudent in an Organized Health Care Education/Training Program1598437477
- Nilofar Abdul ShukurPhysician Assistant1336010529
- Hael Abdulrazeq, MDNeurological Surgery Physician1659934289
- James Abernathy, MDAnesthesiology Physician1942257217
- Karen Abi Chebl, MDStudent in an Organized Health Care Education/Training Program1255179552
- Georges Abi Roustom, MDAnesthesiology Physician1548871908
Verify Eiman Elmileik in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersRhode Island Board of Medical Licensure and Discipline
Search for license LP06490Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
61% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
340 Medicare Part D claims for 57 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D.
Most prescribed
- Atorvastatin Calcium40 claims
- Metformin Hcl25 claims
- Hydrochlorothiazide18 claims
- Lisinopril14 claims
- Omeprazole13 claims
- Gabapentin12 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $20.83
1 payment: food and beverage; the largest payer was Novo Nordisk Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Eiman Elmileik among 88 hematology & oncology physician records in Rhode Island
Eiman Elmileik, MD is one of 88 hematology & oncology physician records with a practice address in Rhode Island. 85% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2022, is newer than 98% of them.
- NPI issued2022 · 98% of these records are older, 0% newer
- In a Medicare fileYes · 85% of these records are
- In the CMS Doctors and Clinicians fileNo · 73% of these records are
- Record last updated2025 · 52% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Rhode Island practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Rhode Island
There are 88 hematology & oncology physician records in Rhode Island.
All 88 in Rhode Island → Every provider in Providence → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Ariel Birnbaum, M.D.Providence, RI 029031942212790
- James Butera, M.D.Providence, RI 029031790797538
- Maria Constantinou, MDProvidence, RI 029031407999444
- Wafik El Deiry, MDProvidence, RI 029031275575714
- Katherine Faricy-Anderson, MD MPHProvidence, RI 029031194940700
- Mary Anne Fenton, M.D.Providence, RI 029031881606622
- Humera Khurshid, MDProvidence, RI 029031013991926
- Adam Olszewski, M.D.Providence, RI 029031467436915
Common questions
What is Eiman Elmileik, MD's NPI number?
Eiman Elmileik, MD's National Provider Identifier (NPI) is 1588314637, issued on Mar 23, 2022. An NPI identifies a provider in billing; it is not a license.
Where is Eiman Elmileik, MD located?
The NPPES record lists a practice address at 593 Eddy St, Providence, RI, 02903. Phone: (401) 444-9375. Providers update this record themselves, so call before visiting.
How can I verify Eiman Elmileik, MD's license?
NPPES lists Rhode Island license number LP06490, as entered by the provider. Search the Rhode Island Board of Medical Licensure and Discipline at https://healthri.mylicense.com/Verification/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Eiman Elmileik, MD prescribe under Medicare Part D?
In 2024, Eiman Elmileik, MD had 340 Medicare Part D claims for 57 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.